\u00a0<\/span><\/h3>\nFundamentally, the focus of this project is evidence-based practice (EBP). In many instances, EBP is characterized by the potential of patient-centered care provision, cost effectiveness of care, and improved expertise of the health care providers. Due to these benefits, EBP is associated with the highest quality of care and positive patient outcomes. In particular, the focus of EBP in this project is the comparison of the best intervention between the use of hemodialysis and peritoneal dialysis in reduction of incidences of mortalities caused by end-stage renal diseases.\u00a0 Before the initiation of the project, the organizational readiness to embrace the project was determined. Based on the evaluation, the organization showed moderate preparedness for the integration of evidence-based practice in the organization. The proposed solution for determining the best intervention between hemodialysis treatment and peritoneal dialysis treatment was determined through a retrospective study. The Trans-Theoretical Model of behavioral change was utilized to facilitate the adoption of change in the organization. This model helped in facilitating the communication with stakeholders since provides information in a manner that prompts individuals to make decisions to change their behaviors. Consequently, an implementation plan was developed. The project allocated a period of nine months for patients follow-up to determine the clinical outcomes. Specifying the timeframe also helped in defining resources needed for the implementation of the project.\u00a0<\/span>\u00a0<\/span><\/p>\n\u00a0<\/span>Section A: Organizational Culture and Readiness Assessment<\/span><\/b>\u00a0<\/span><\/h2>\nThe survey tool that was used in this research was obtained from the book authored by <\/span>Melnyk and Fineout-Overholt (2011).<\/span> The tool provides insights into the readiness of an organization in integrating evidence-based practice into its systems. It consists of 19 survey questions that explore various organizational issues that are critical for successful integration of evidence-based practice. The questions are rated from one to five. The lowest rate represents none at all response while the highest rate represents very much response. The score for my survey was 75%, which shows that there is moderate preparedness for the integration of evidence-based practice in the organization. The highest survey scores included those of the questions that focused on whether the mission reflects evidence-based practice, commitment of the nursing staff to evidence-based practice, and championing level of the healthcare providers. The survey questions with the lowest scores included those concerning the readiness of the physicians and availability of fiscal resources to support evidence-based practice. The overall survey result shows that evidence-based practice can be successfully introduced in the firm. The success can be seen in its current practices that align with the requirements of successful integration of evidence-based practice in an organization.\u00a0<\/span>\u00a0<\/span><\/p>\nThere exist possible barriers that might hinder the adoption of evidence-based practice in our organization. One of them is the low level of commitment from the physicians towards the adoption of evidence-based practice. Efforts need to be embraced to ensure that all the healthcare providers support to use of evidence-based practice in the provision of healthcare. The other potential barrier is the limited fiscal resources needed to support evidence-based practice in the organization. Healthcare organizations are supposed to support the adoption of evidence-based practice in their settings. The support could be in the form of providing learning materials and organizing training for the healthcare providers. This challenge can be addressed by raising the level of awareness of the management and leadership of the organization on the importance of evidence-based practice.\u00a0<\/span>\u00a0<\/span><\/p>\nSection B: Proposal\/Problem Statement and Literature Review<\/span><\/b>\u00a0<\/span><\/h2>\nBackground of the Topic<\/span><\/b>\u00a0<\/span><\/h3>\nEnd stage renal disease is one of the health problems that affect a significant proportion of the world\u2019s population. It is estimated that 750, 000 patients are diagnosed with end stage renal disease in the US on an annual basis. About 2 million people are also affected by the disease globally (University of California San Francisco, n.d.). The World Health Organization reports that about 1.2 million people lost their lives to end stage renal disease in 2015. The rate represented an increase by 32% when compared to the statistics of the year 2005. Globally, approximately 5-10 million people die annually due to chronic diseases of the kidney (<\/span>Luyckx, Tonelli,&Stanifer, 2018<\/span>). The prevalence of end-stage kidney disease is high in women than in men. There is disproportionate prevalence of the disease across races. For instance, it is more common in individuals with non-Hispanic blacks when compare to non-Hispanic white and non-Hispanic Asians (CDC, 2019).\u00a0<\/span>\u00a0<\/span><\/p>\nEnd stage renal disease is characterized by the loss of kidney function and represents glomerular filtration rate below 13 ml\/min (<\/span>Bujang<\/span>et al<\/span><\/i>., 2017<\/span>). The disease is associated with risk factors that include diabetes, infections such as HIV\/AIDS, malaria, and hypertension (<\/span>Luyckx<\/span>et al<\/span><\/i>., 2018<\/span>). The management of end-stage renal disease relies mainly on the use of peritoneal dialysis and hemodialysis. These methods of management are effective in preventing mortalities caused by uremia. The selection of a method of treatment depends on a wide range of factors such as patient\u2019s preferences, logistical considerations of the existing treatment facilities, comorbidities, and timing or acuity of uremia (<\/span>Zhou <\/span>et al<\/span><\/i>., 2019<\/span>).\u00a0<\/span>\u00a0<\/span><\/p>\nThe duration of survival and mortality rates among end-stage renal disease patients on hemodialysis and peritoneal dialysis has been an issue of concern to patients and healthcare providers. Controversy exists as to whether there is survival advantage between peritoneal dialysis and hemodialysis (<\/span>Xue<\/span>et al<\/span><\/i>., 2019<\/span>). The findings reported in observational studies on the survival rates between the two treatment approaches have been inconsistent. Some observational studies have shown that there is an initial survival advantage with the use of peritoneal dialysis within the first 2 years of diagnosis with end stage renal disease. The mortality risk increases significantly after this period. Other studies have shown the lack of clear mortality between the two treatments, thereby, attributing the mortalities to residual confounding factors (<\/span>Zhou <\/span>et al<\/span><\/i>., 2019<\/span>).\u00a0<\/span>\u00a0<\/span><\/p>\nStudies conducted in the past can provide insights into the mortalities associated with hemodialysis and peritoneal dialysis in patients suffering from end-stage renal disease. A meta-analysis conducted by <\/span>Xue<\/span>et al<\/span><\/i>. (2019) <\/span>showed that there was no statistical difference in mortalities in end-stage kidney disease patients on hemodialysis and peritoneal dialysis. Instead, the analysis revealed that the benefits of these treatment methods outweigh their potential risks. The study by <\/span>Yang <\/span>et al<\/span><\/i>. (2015) <\/span>revealed that hemodialysis was associated with better survival results when compared to those started in hemodialysis. However, there was no significant difference in mortalities reported among young as well as healthier patients. The findings reported by these scholars cannot be relied upon wholly as the research was confounded by selection bias. A study by <\/span>Wong <\/span>et al<\/span><\/i>., (2018) <\/span>showed that there were no differences in mortalities among patients on hemodialysis and peritoneal dialysis.\u00a0 <\/span>Rufino<\/span>et al<\/span><\/i>. (2011) <\/span>argue that while peritoneal dialysis might be associated with better survival outcomes, its beneficial effects are short-lived and cannot be the basis for its adoption over hemodialysis. Therefore, it makes it evident that further studies exploring the mortalities associated with these treatment modalities are conducted, hence, the need for this proposed research.\u00a0<\/span>\u00a0<\/span><\/p>\nPICOT<\/span><\/b>\u00a0<\/span><\/h2>\nThe PICOT question for this research is; In patients with chronic kidney disease, will the use of hemodialysis as compared to peritoneal dialysis reduce incidences of mortalities caused by end-stage renal diseases within a period of 9 months?\u00a0<\/span>\u00a0<\/span><\/p>\nPurpose of the Project and Significance to Nursing<\/span><\/b>\u00a0<\/span><\/h2>\nThe purpose of this proposed project is to investigate whether the use of hemodialysis will result in incidence of mortalities caused by end stage renal disease within nine months when compared to the use of peritoneal dialysis. On the other hand, the use of evidence-based practice data has gained significant need in the modern practice of nursing. As a result, this project will act as a source of evidence-based data on the effectiveness of the two treatment approaches in end stage renal disease. The proposal will raise the level of knowledge among the nurses on the type of management that is appropriate to the patients with end stage renal disease they serve on a regular basis. The research will also inform policy changes in healthcare organizations. The results might shift the focus of management of end stage renal disease in the institution. Lastly, it can stimulate more researches into the topic among the nurses. The results of the study might act as a basis for future researches conducted by the nurses to explore the survival benefits between the two treatment methods of end stage renal disease.\u00a0<\/span>\u00a0<\/span><\/p>\nSection C: Solution Description\u00a0<\/span><\/b>\u00a0<\/span><\/h2>\nProposed Solution<\/span><\/b>\u00a0<\/span><\/h3>\nThe PICOT question for this research is; In patients with chronic kidney disease, will the use of hemodialysis as compared to peritoneal dialysis reduce incidences of mortalities cause by end stage renal disease within a period of 9 months? Therefore, the proposed intervention for this research would be a retrospective study that will be conducted in our unit. Patients suffering from end-stage renal failure will be assigned to either hemodialysis treatment or peritoneal dialysis treatment. The participants will then be followed for a period of nine months to determine the clinical outcomes. The outcome of focus would be the mortality rate reported in the two groups of patients.<\/span>\u00a0<\/span><\/p>\nThe above-proposed solution aligns with previous studies conducted on the topic. <\/span>Wang <\/span>et al<\/span><\/i>. (2018) <\/span>conducted a study to compare the survival rate between patients with end-stage renal disease on hemodialysis and peritoneal dialysis in the era of icodextrin treatment. The outcomes showed that icodextrin has the ability of attenuating the survival advantage among patients on peritoneal dialysis unlike in hemodialysis. Another study by <\/span>Zhou <\/span>et al<\/span><\/i>., (2019)<\/span> compared early mortality rates among patients on hemodialysis and peritoneal dialysis who were transitioned with an optimal start at the outpatient clinic. The outcomes showed that there were no differences in early mortality rate among patients on hemodialysis and peritoneal dialysis.\u00a0<\/span>\u00a0<\/span><\/p>\nGon\u00e7alves <\/span>et al<\/span><\/i>. (<\/span>2015) also conducted a study that aimed at comparing the quality of life of patients with chronic kidney disease on either peritoneal dialysis or hemodialysis. The results showed that peritoneal dialysis was associated with better quality of life when compared to hemodialysis. Therefore, these studies show that the proposed intervention in this research can provide a better understanding of the topic.\u00a0<\/span>\u00a0<\/span><\/p>\n\u00a0<\/span>The intervention is realistic for our setting. It has a large number of patients seeking hemodialysis and peritoneal dialysis care. Therefore, it is expected that an adequate number of participants will be obtained for the research. The adequacy will also imply that the conclusions that will be reached will support evidence-based practice in the management of end-stage renal disease.\u00a0<\/span>\u00a0<\/span><\/p>\nOrganizational Culture<\/span><\/b>\u00a0<\/span><\/h2>\nThe proposed solution is consistent with the culture and resources of our organization. <\/span>Vanderbloemen (2018)<\/span> has defined culture as the manner in which organizational tasks and decisions are undertaken. Our organization recognizes the fact that evidence-based practice is an important aspect that enhances the quality of care. As a result, it has invested its resources in initiatives that will promote evidence-based practice. This includes supporting studies that explore the use of different treatment approaches to case management in our institution. The healthcare providers are also trained on evidence-based practice. They constantly appraise evidence on the use of various clinical interventions to improve the health outcomes of their patients. Therefore, it is believed that the supportive culture in the organization will enhance the adoption of the proposed intervention.<\/span>\u00a0<\/span><\/p>\nExpected Outcomes<\/span><\/b>\u00a0<\/span><\/h2>\nIt is expected that this proposed intervention will provide insight into the effectiveness of hemodialysis and peritoneal dialysis in reducing the mortality rate among patients suffering from end-stage renal failure. The intervention will enable clinicians to determine the most effective treatment approach for these patients, with the aim of optimizing their health outcomes. Through this research, it is expected that the outcomes will agree or contradict with those reported in other studies. Therefore, it will inform the clinical practice in relation to the management of end-stage renal failure.\u00a0<\/span>\u00a0<\/span><\/p>\nMethod to Achieve the Outcomes<\/span><\/b>\u00a0<\/span><\/h2>\nThe participants in this study will be followed throughout the study period. Their response to the treatment will be examined using the symptoms and adverse reactions they report to the healthcare team. By the end of the study period, statistics on the survival rate among the patients on hemodialysis and peritoneal dialysis will be computed to provide insights into their efficacy and safety. Some of the barriers that might be experienced include low adherence to the prescribed treatment among the patients and their lack of willingness to utilize a treatment approach from the two methods. These barriers will be eliminated through active follow-up of the patients and informing them on the two treatment approaches for them to make informed decisions. One of the assumptions made in this intervention is that any mortality that will be reported during the study period will be due to complications of hemodialysis or peritoneal dialysis alone.\u00a0<\/span>\u00a0<\/span><\/p>\nOutcome Impact<\/span><\/b>\u00a0<\/span><\/h2>\nThe results from this intervention will inform clinical practice. They will inform the decision on whether patients suffering from end-stage renal disease should be placed on hemodialysis or peritoneal dialysis. The results will also form a basis of other studies into the topic as clinicians try to examine additional ways of optimizing the care given to patients suffering from end-stage renal disease. The intervention will also promote the provision of safe and quality care to these patients since the most effective treatment approach will be utilized in managing their conditions.\u00a0<\/span>\u00a0<\/span><\/p>\nSection D: Change Model<\/span><\/b>\u00a0<\/span><\/h2>\nSelected Model and its Applicability to My Project<\/span><\/b>\u00a0<\/span><\/h3>\nThe selected model for my evidence-based proposal is Trans-theoretical Model of behavioral change. Prochaska and DiClemente developed it in the 1970s. The model provides information on the manner in which individuals make decisions to change their behaviors. It assumes that behavioral change does not occur in a faster rate but continuously through incremental improvement of behaviors (<\/span>Glanz, Rimer & Viswanath, 2015<\/span>). This model is relevant to my project because it recognizes the fact that change occurs in a sequential process and not a drastic event. The introduction of my project requires sequential interventions in the organization. The staffs have to be made aware about the need for the change, behaviors that they should adopt, and ways of sustaining the desired success. Therefore, the increased focus of the model of stimulating behavior change among the adopters make it an important framework for my project as it mainly relies on the change in behavior among nurses working in the renal unit.\u00a0<\/span>\u00a0<\/span><\/p>\nSteps of Change in the Model<\/span><\/b>\u00a0<\/span><\/h2>\nAccording to the theory, behavioral change occurs in a series of steps. They include precontemplation, contemplation, preparation, action, maintenance, and termination. Precontemplation is the first stage in the Trans-theoretical Model of behavioral change. In this stage, those to be affected by the change agent do not have any intentions to embrace actions in their near future. They do not perceive their behaviors as being problematic or having undesired consequences to them or others. Therefore, they underestimate any need for behavioral change in their organizations (<\/span>Sharma, 2017<\/span>). Contemplation is the second phase of the Trans-theoretical Model of behavioral change. The stage is characterized by people showing intentions to embrace healthy behaviors in their near future. They have recognized that their behaviors are problematic and have undesired outcomes to them and others (<\/span>Glanz <\/span>et al<\/span><\/i>., 2015)<\/span>. Despite this awareness, they are still ambivalent on the need to change their behaviors.\u00a0<\/span>\u00a0<\/span><\/p>\nPreparation is the third stage in the Trans-theoretical Model of behavioral change. The people are ready to embrace change within a period of one month in this stage. They begin exploring small incremental steps that will enable them to achieve their desired behavioral change. The main reason for embracing change interventions is that they perceive the change to have healthier outcomes in their lives. The fourth phase is action stage. This stage is characterized by people who have recently adopted change behaviors planning to sustain the behavior change. They modify their behaviors as a way of promoting continuous change and improvement in their healthy behaviors (<\/span>Sharma, 2017<\/span>). The fifth stage is maintenance stage. The adopters in this stage have sustained the desired behaviors for a period and are willing to continue with the behavioral change going further. They focus on adopting interventions that would prevent or reduce incidences of relapse of the earlier behaviors. The last stage in the model is termination. The people in this stage are characterized by lacking any desire to return to their previously held unhealthy behaviors. They strongly believe that they will not experience relapse of their unhealthy behaviors (<\/span>Glanz <\/span>et al<\/span><\/i>., 2015)<\/span>. Therefore, these people are ready to explore other ways in which extra benefits of the behavioral change can be achieved.\u00a0<\/span>\u00a0<\/span><\/p>\nApplication of Each Stage on Project Implementation<\/span><\/b>\u00a0<\/span><\/h2>\nEach of the above stages of the Trans-theoretical Model is applicable to my change project. In precontemplation stage, the nurses do not plan to take any action related to the evaluation of the survival rate between patients on hemodialysis and peritoneal dialysis. They do not understand that these treatment methods might have undesired effect on the survival rate of patients suffering from end-stage renal disease. The nurses in contemplation stage begin to understand the need for examining the survival rate among end-stage renal disease patients on peritoneal dialysis and hemodialysis. They see the need to engage in research on this area in their near future. However, they are still skeptical on embracing the change (<\/span>